Avenue Therapeutics ATXI
OTC ATXI
$0.38 -0.03 (-8.33%)
As of: Oct 23, 2026 · 9:30 AM EDT

Avenue Therapeutics (ATXI) Interest Coverage Ratio (2016 - 2017)

Updated

Avenue Therapeutics' (ATXI) Interest Coverage Ratio came in at -38.85 for FY2017, compared with -5.66 in FY2016.

Analysis

Avenue Therapeutics (ATXI) Interest Coverage Ratio (2016 - 2017) Analysis & Trends

  • Business Quant data shows ATXI's Interest Coverage Ratio at -5.66 in FY2016 and -22.53 in FY2015.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover (Qtr)
1 Eli Lilly 1,127.42 Bn 1,096.00 Bn 19.71 Bn -
2 Johnson & Johnson 633.77 Bn 553.63 Bn 17.30 Bn 28.50
3 AbbVie 505.19 Bn 478.30 Bn 12.70 Bn -
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn -
5 Novartis Ag 290.00 Bn 253.99 Bn 11.24 Bn 10.28
6 Astrazeneca 265.19 Bn 238.88 Bn 12.86 Bn 7.27
7 Amgen 238.02 Bn 193.42 Bn 7.24 Bn 5.22
8 Gilead Sciences 194.79 Bn 168.99 Bn 6.22 Bn -42.08
9 Pfizer 171.11 Bn 117.76 Bn 10.94 Bn -
10 Avenue Therapeutics 1.27 Mn -9.65 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2017 -26.87
Jun 30, 2017 -18.75
Mar 31, 2017 -5.31
Dec 31, 2016 -3.25
Sep 30, 2016 -4.30
Jun 30, 2016 -7.33
Mar 31, 2016 -9.88
API Access

Avenue Therapeutics Interest Coverage Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-coverage-ratio&ticker=ATXI&period=max&api_key=YOUR_API_KEY